Drug details
Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir  alafenamide tablets)
type of HIV, ART Combos
Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) is a four-drug combination of a human immunodeficiency virus (HIV-1) protease inhibitor, a CYP3A inhibitor, and two HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated as a complete regimen for the treatment of HIV-1 infection in adults who have no prior antiretroviral treatment history or who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months and have no known substitutions associated with resistance to darunavir or tenofovir.
The drug is often used to treat HIV .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- loss of appetite,
- dark urine,
- vomiting,
- diarrhea,
- fever,
- swollen glands,
- night sweats,
- weight loss,
- tiredness,
- stomach pain,
- clay-colored stools,
- yellowing of the skin or eyes (jaundice),
- dizziness,
- wheezing,
- weakness,
- sore throat,
- burning eyes,
- skin pain,
- red or purple skin rash with blistering and peeling,
- little or no urination,
- increased thirst,
- increased urination,
- menstrual changes, and
- right-sided upper stomach pain,
- trouble breathing,
- feeling cold,
- cold sores,
- trouble speaking or swallowing,
- problems with balance or eye movement,
- swelling in your neck or throat (enlarged thyroid),
- impotence
- unusual muscle pain,
- prickly feeling,
- swelling around your midsection,
- irregular heart rate,
The following drugs are related to Symtuza, either as a replacement or used together:
- Ziagen (abacavir sulfate)
- Epzicom (abacavir sulfate and lamivudine tablets)
- Trizivir (abacavir sulfate, lamivudine, and zidovudine)
- Triumeq (abacavir, dolutegravir, and lamivudine film-coated tablets)
- Aptivus (tipranavir)
- Evotaz (atazanavir and cobicistat tablets for oral administration)
- Reyataz (atazanavir sulfate)
- Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
- Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide tablets)
- Cabenuva (cabotegravir; rilpivirine extended-release injectable suspension)
- Vocabria (cabotegravir tablets for oral use)
- Tybost (cobicistat tablets)
- Combivir (lamivudine, zidovudine)
- Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate tablets)
- Crixivan (indinavir sulfate)
- Prezista (darunavir)
- Prezcobix (darunavir and cobicistat tablets)
- Rescriptor (delavirdine mesylate)
- Descovy (emtricitabine and tenofovir alafenamide tablets)
- Videx EC (didanosine delayed-release capsules)
- Videx (didanosine pediatric powder for oral solution)
- Dovato (dolutegravir and lamivudine tablets)
- Juluca (dolutegravir and rilpivirine tablets, for oral use)
- Tivicay (doutegravir 50mg tablets)
- Edurant (rilpivirine tablets)
- Sustiva (efavirenz)
- Vitekta (elvitegravir tablets)
- Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide tablets)
- Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir df)
- Emtriva (emtricitabine)
- Truvada (emtricitabine tenofovir df)
- Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide fixed-dose combination tablets)
- Fuzeon (enfuvirtide)
- Epivir (lamivudine)
- Intelence (etravirine tablets)
- Lexiva (fosamprenavir calcium)
- Rukobia (fostemsavir extended-release tablets)
- Hivid (zalcitabine)
- Invirase (saquinavir mesylate)
- Isentress (raltegravir tablets)
- Kaletra Capsules (lopinavir, ritonavir capsules)
- Kaletra Tablets (lopinavir, ritonavir tablets)
- Sunlenca (lenacapavir tablets and injection)
- Selzentry (maraviroc)
- Viracept (nelfinavir mesylate)
- Viramune (nevirapine)
- Viramune XR (nevirapine extended-release tablets, for oral use)
- Norvir (ritonavir capsules, oral solution)
- Norvir Soft Gelatin Capsules (ritonavir)
- Retrovir (zidovudine)
- Retrovir IV (zidovudine injection)
- Zerit (stavudine)
- Viread (tenofovir disoproxil fumarate)